论文部分内容阅读
目的:本文就联合应用双岐三联活菌和蒙脱石散剂治疗急性细菌性肠炎的效果进行了讨论和分析。方法:就我院2015年03月01日至2015年09月31日进行就诊的80例急性细菌性肠炎的患者进行讨论和分析。对照组患者的干预组患者分别使用氟哌酸和联合应用双岐三联活菌和蒙脱石散剂的治疗方式,并对比两组患者的疗效。结果:通过上述实验的对比分析后发现,对照组患者的临床治疗效果明显低于干预组患者(P<0.05),差异具有统计学意义。结论:通过上述实验研究结果的对比分析后发现,对于急性细菌性肠炎的患者经由联合应用双岐三联活菌和蒙脱石散剂的治疗方式能够有效的提高患者的临床治疗效果,值得大力推广和应用。
OBJECTIVE: This article discusses and analyzes the effect of combined application of Bifid triple viable montmorillonite and montmorillonite powder in the treatment of acute bacterial enteritis. Methods: 80 patients with acute bacterial enteritis treated in our hospital from March 1, 2015 to September 31, 2015 were discussed and analyzed. The patients in the control group were treated with norfloxacin and the combined treatment of live bifidobacterium and montmorillonite respectively, and compared the curative effect of the two groups of patients. Results: The comparative analysis of the above experiments found that the clinical efficacy of the control group patients was significantly lower than the intervention group (P <0.05), the difference was statistically significant. Conclusion: The comparative analysis of the above experimental results found that patients with acute bacterial enteritis through the joint application of Bifid triple viable montmorillonite and monotherapy treatment can effectively improve the clinical efficacy of patients, it is worth to promote and application.